Dr. Rajeev S. Motiwala, MD

Dr. Motiwala practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Motiwala's NPI, 1255325957, was assigned on September 8, 2005. Dr. Motiwala holds New York license 233716.

Dr. Motiwala's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Motiwala's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Motiwala is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Motiwala to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Motiwala practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Motiwala's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Motiwala is licensed in New York.

CMS data shows 490 Medicare services from Dr. Motiwala across 11 procedure codes in 2024, for 251 Medicare patients. Medicare paid $46,281 for them.

CMS counts 251 Medicare patients who saw Dr. Motiwala in 2024. The largest group is 75 to 84, with 103 patients. 75% of them have high cholesterol, and 72% have arthritis. 15% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Motiwala's median patient age at 63, with 52% women.

In 2024, Dr. Motiwala wrote 487 Medicare Part D claims for 95 patients. 86% of them were for generic drugs. CMS names the drug for 389 of them, across 14 drugs with 11 or more claims each, at $319,280 in total drug cost. In 2023, CMS named 367 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Motiwala for performance year 2024, reported as part of a group. Dr. Motiwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Motiwala as offering telehealth.

Dmand AI links 6 papers to Dr. Motiwala in 2015. The most frequent topics are Diagnosis, Differential, Magnetic Resonance Imaging and Muscle, Skeletal. Dr. Motiwala has published most often in J Clin Neuromuscul Dis. Dr. Motiwala's most frequent co-authors are Susan C. Shin, MD, Lan Zhou, MD and Rachel B. Brandstadter, MD.

CMS Open Payments shows 7 general payments to Dr. Motiwala from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $123.